Please sign in to follow a disease.
Muscle-Saving combo: exercise and diet may counteract Semaglutide-Related muscle loss in seniors
NCT ID NCT06497595
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This study tests whether a structured exercise and nutrition program can slow the loss of muscle mass, strength, and function in adults aged 65 and older with type 2 diabetes and obesity who are taking semaglutide. Participants receive either standard health advice or a 26-week program including online exercise sessions and personal dietary counseling. The goal is to see if these lifestyle changes can help preserve physical ability while managing weight and blood sugar.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide (Wegovy) plus a 26-week exercise and nutritional counseling program
- What this could lead to
- If successful, this approach could help older adults on semaglutide preserve muscle strength and function, reducing frailty and fall risk.
- What could go wrong
- This is a small, early-stage trial with 60 participants, so results may not apply broadly. The exercise and diet program requires high adherence, which can be challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hadassah Medical Center
NOT_YET_RECRUITINGJerusalem, Israel, 5251108, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sheba medical center
RECRUITINGRamat Gan, Israel, 52621, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test